These findings provide a new perspective on the role of CX3CL1 in ccRCC and suggest the potential of a combined treatment strategy involving CX3CL1-mediated tumor immunotherapy and ferroptosis regulation in ccRCC. Here, CX3CL1 is linked to neoplasm.